Inspira Tech Signs LOI with Northwestern Memorial for ART100 Device
Ticker: IINNW · Form: 6-K · Filed: Jan 2, 2024 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: medical-device, partnership, clinical-trial, letter-of-intent
TL;DR
**Inspira Technologies just landed a key LOI with Northwestern Memorial for their ART100 device, big step for clinical adoption!**
AI Summary
Inspira Technologies Oxy B.H.N. Ltd. announced on January 2, 2024, that it signed a Letter of Intent (LOI) with Northwestern Memorial Hospital in Chicago for the clinical use of its INSPIRA ART100 device. This LOI is a significant step towards the potential adoption and commercialization of Inspira's medical technology in a major U.S. hospital. For investors, this matters because it signals progress in gaining clinical validation and market access, which could lead to future revenue growth and increased stock value if the device proves successful and widely adopted.
Why It Matters
This LOI with a prominent hospital like Northwestern Memorial could pave the way for the INSPIRA ART100 device to be used clinically, potentially boosting Inspira Technologies' market credibility and future sales.
Risk Assessment
Risk Level: medium — While positive, an LOI is not a definitive contract and the clinical use and commercial success of the INSPIRA ART100 device are not yet guaranteed.
Analyst Insight
A smart investor would monitor future announcements regarding the progress of this Letter of Intent, specifically looking for definitive agreements, timelines for clinical trials, and initial results from the use of the INSPIRA ART100 device at Northwestern Memorial Hospital, as these could significantly impact the company's valuation.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — the registrant issuing the 6-K filing
- Northwestern Memorial Hospital (company) — hospital signing the Letter of Intent for clinical use
- INSPIRA ART100 Device (product) — medical device subject of the Letter of Intent
- Dagi Ben-Noon (person) — signer of the 6-K report on behalf of Inspira Technologies
- January 2, 2024 (date) — date of the press release and 6-K filing
Forward-Looking Statements
- Inspira Technologies will announce further details or a definitive agreement regarding the clinical use of the INSPIRA ART100 device at Northwestern Memorial Hospital. (Inspira Technologies Oxy B.H.N. Ltd.) — medium confidence, target: Q2 2024
- The INSPIRA ART100 device will begin clinical use at Northwestern Memorial Hospital. (INSPIRA ART100 Device) — low confidence, target: Q4 2024
FAQ
What is the purpose of the 6-K filing by Inspira Technologies Oxy B.H.N. Ltd.?
The 6-K filing, dated January 2, 2024, is to report that Inspira Technologies Oxy B.H.N. Ltd. issued a press release titled "Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device," which is furnished as Exhibit 99.1.
Which specific document is incorporated by reference into Inspira Technologies' registration statements?
The first and second paragraphs and the section titled "Forward-Looking Statements" from the press release issued on January 2, 2024, are incorporated by reference into the Registrant’s Registration Statements on Form F-3 (Registration No. 333-266748) and Form S-8 (Registration No. 333-259057).
What is the name of the medical device mentioned in the Letter of Intent?
The medical device mentioned in the Letter of Intent with Northwestern Memorial Hospital is the INSPIRA™ ART100 Device.
Who signed the 6-K report on behalf of Inspira Technologies Oxy B.H.N. Ltd.?
The 6-K report was signed by Dagi Ben-Noon on behalf of Inspira Technologies Oxy B.H.N. Ltd. on January 2, 2024.
What is the Commission File Number for Inspira Technologies Oxy B.H.N. Ltd.?
The Commission File Number for Inspira Technologies Oxy B.H.N. Ltd. is 001-40303.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-01-02 09:05:02
Filing Documents
- ea190978-6k_inspiratech.htm (6-K) — 11KB
- ea190978ex99-1_inspira.htm (EX-99.1) — 10KB
- 0001213900-24-000068.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 2, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2